Compare CVGW & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVGW | BWAY |
|---|---|---|
| Founded | 1924 | 2003 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Specialty Foods | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 479.9M | 450.8M |
| IPO Year | 2002 | N/A |
| Metric | CVGW | BWAY |
|---|---|---|
| Price | $28.54 | $16.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $33.50 | $13.25 |
| AVG Volume (30 Days) | ★ 279.6K | 142.0K |
| Earning Date | 06-08-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.84% | N/A |
| EPS Growth | ★ 1950.00 | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $648,434,000.00 | N/A |
| Revenue This Year | N/A | $309.69 |
| Revenue Next Year | N/A | $26.21 |
| P/E Ratio | $701.00 | ★ $81.98 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $18.40 | $8.59 |
| 52 Week High | $28.72 | $26.63 |
| Indicator | CVGW | BWAY |
|---|---|---|
| Relative Strength Index (RSI) | 66.74 | 59.52 |
| Support Level | $26.73 | $14.56 |
| Resistance Level | N/A | $16.63 |
| Average True Range (ATR) | 0.60 | 0.69 |
| MACD | 0.06 | 0.39 |
| Stochastic Oscillator | 98.56 | 94.39 |
Calavo Growers Inc is engaged in the sourcing, packing, and distribution of fresh avocados, tomatoes, and papayas, and the processing of guacamole and other avocado products. The company delivers products to retail grocers, club and mass-merchandise stores, foodservice operators, and wholesalers, sourcing avocados from California, Mexico, and other key growing regions. Its operations include sorting, packing, ripening, and shipping fresh produce, and processing and packaging fresh and frozen guacamole. The company operates through two segments: Fresh, including avocados, tomatoes, papayas, and other fresh produce products, and Prepared, including guacamole and avocado pulp, with the majority of revenue generated from the Fresh segment and geographically from the United States.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.